Nutrient sensor-mediated programmed nonalcoholic fatty liver disease in low birthweight offspring

American Journal of Obstetrics and Gynecology

Volumn 207, Issue 4, 2012, Pages 308.e1-308.e6

  Wolfe, Diana ^a   Gong, Ming ^a,b   Han, Guang ^a   Magee, Thomas R ^a,b   Ross, Michael G ^a,b   Desai, Mina ^a,b  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

lipogenesis; lipolysis; nutrient metabolic sensors; programmed fatty liver

Indexed keywords

FAS ANTIGEN; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; FEMALE; FETUS; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; LIVER; LOW BIRTH WEIGHT; MALE; MARE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION;

EID: 84866902622     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.07.033     Document Type: Article

References (28)

1. Y. Falck-Ytter, Z.M. Younossi, G. Marchesini, A.J. McCullough Clinical features and natural history of nonalcoholic steatosis syndromes Semin Liver Dis 21 2001 17 26
2. T. Yamamoto, H. Shimano, Y. Nakagawa SREBP-1 interacts with hepatocyte nuclear factor-4 alpha and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes J Biol Chem 279 2004 12027 12035
3. G. Blander, L. Guarente The Sir2 family of protein deacetylases Annu Rev Biochem 73 2004 417 435
4. C. Canto, Z. Gerhart-Hines, J.N. Feige AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Nature 458 2009 1056 1060
5. X. Hou, S. Xu, K.A. Maitland-Toolan SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase J Biol Chem 283 2008 20015 20026
6. M. Yamada, D. Wolfe, G. Han, S.W. French, M.G. Ross, M. Desai Early onset of fatty liver in growth-restricted rat fetuses and newborns Congenit Anom (Kyoto) 51 2011 167 173
7. B. Ponugoti, D.H. Kim, Z. Xiao SIRT1 deacetylates and inhibits SREBP-1c activity in regulation of hepatic lipid metabolism J Biol Chem 285 2010 33959 33970
8. T. Porstmann, C.R. Santos, B. Griffiths SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth Cell Metab 8 2008 224 236
9. E.J. Jung, S.W. Kwon, B.H. Jung, S.H. Oh, B.H. Lee Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver J Lipid Res 52 2011 1617 1625
10. J.T. Rodgers, C. Lerin, Z. Gerhart-Hines, P. Puigserver Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways FEBS Lett 582 2008 46 53
11. S. Jager, C. Handschin, J. St-Pierre, B.M. Spiegelman AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha Proc Natl Acad Sci U S A 104 2007 12017 12022
12. M. Fulco, Y. Cen, P. Zhao Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt Dev Cell 14 2008 661 673
13. J.T. Rodgers, C. Lerin, W. Haas, S.P. Gygi, B.M. Spiegelman, P. Puigserver Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 Nature 434 2005 113 118
14. C.S. Costa, T.O. Hammes, F. Rohden SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis Obes Surg 20 2010 633 639
15. Y. Colak, O. Ozturk, E. Senates SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease Med Sci Monit 17 2011 HY5 HY9
16. Y. Yamazaki, I. Usui, Y. Kanatani Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice Am J Physiol Endocrinol Metab 297 2009 E1179 E1186
17. J. Shang, L.L. Chen, F.X. Xiao, H. Sun, H.C. Ding, H. Xiao Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase Acta Pharmacol Sin 29 2008 698 706
18. V. Nobili, A. Alisi, N. Panera, C. Agostoni Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review Pediatr Endocrinol Rev 6 2008 241 247
19. A. Alisi, N. Panera, C. Agostoni, V. Nobili Intrauterine growth retardation and nonalcoholic fatty liver disease in children Int J Endocrinol 2011 2011 269853
20. M. Desai, D. Gayle, J. Babu, M.G. Ross The timing of nutrient restriction during rat pregnancy/lactation alters metabolic syndrome phenotype Am J Obstet Gynecol 196 2007 555 557
21. M. Desai, D. Gayle, J. Babu, M.G. Ross The timing of nutrient restriction during rat pregnancy/lactation alters metabolic syndrome phenotype Am J Obstet Gynecol 196 2007 555.e1 555.e7
22. M. Desai, D. Gayle, J. Babu, M.G. Ross Programmed obesity in intrauterine growth-restricted newborns: modulation by newborn nutrition Am J Physiol Regul Integr Comp Physiol 288 2005 R91 R96
23. N. Braidy, G.J. Guillemin, H. Mansour, T. Chan-Ling, A. Poljak, R. Grant Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats PLoS One 6 2011 e19194
24. D.L. Brautigan, C.L. Shriner Methods to distinguish various types of protein phosphatase activity Methods Enzymol 159 1988 339 346
25. J. Bennett Chloroplast phosphoproteins: evidence for a thylakoid-bound phosphoprotein phosphatase Eur J Biochem 104 1980 85 89
26. P.D. Gluckman, M.A. Hanson The consequences of being born small: an adaptive perspective Horm Res 65 suppl 3 2006 5 14
27. M. You, Q. Cao, X. Liang, J.M. Ajmo, G.C. Ness Mammalian sirtuin 1 is involved in the protective action of dietary saturated fat against alcoholic fatty liver in mice J Nutr 138 2008 497 501
28. T. Ejlertsen, H. Schonheyder Branhamella catarrhalis as a cause of multiple subpleural abscesses Scand J Infect Dis 23 1991 117 118